Beijing GoBroad Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Beijing GoBroad Hospital
RECRUITINGPhase 1NCT06980597
A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
This study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-108 in relapsed/refractory autoimmune diseases.
Sponsor: Beijing GoBroad HospitalEnrolling: 442 locations
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+1
RECRUITINGPhase 1NCT07167537
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
This study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-CD19-GDT in relapsed/refractory autoimmune diseases.
Sponsor: Beijing GoBroad HospitalEnrolling: 441 location
Systemic Sclerosis (SSc)Primary Sjogren's Syndrome
RECRUITINGPhase 1 / Phase 2NCT06947460
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
This is a single-center, open-label, non-randomized, single-arm clinical trial. Patients with refractory lupus neritis (SLE-LN), systemic sclerosis (SSc), and primary Sjogren...
Sponsor: Beijing GoBroad HospitalEnrolling: 451 location
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension